2013 Fiscal Year Final Research Report
Elucidation of the physiological and pharmacokinetic significance of the renal drug excretion systems
Project/Area Number |
23390138
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Applied pharmacology
|
Research Institution | Ritsumeikan University (2013) Kyoto University (2011-2012) |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
MOTOHASHI Hideyuki 京都大学, 医学研究科, 助教
YONEZAWA Atsushi 京都大学, 医学研究科, 助教 (90452341)
|
Project Period (FY) |
2011-04-01 – 2014-03-31
|
Keywords | 薬物動態学 / 薬学 / 生理学 / 薬物トランスポータ / 医薬品適正使用 |
Research Abstract |
To elucidate the physiological and pharmacokinetic significance of the renal drug transporters, we carried out the pharmacokinetic and toxicokinetic analyses of various drugs using transporter-deficient mice. It was demonstrated that the contribution of renal drug transporters to urinary excretion vary among substrate drugs. In addition, it was found that loss of transporter function lead to the changes in blood and tissue concentration of drugs, which in turn causes the adverse reaction of drugs.
|
-
-
[Journal Article] Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins2014
Author(s)
Kato K, Mori H, Kito T, Yokochi M, Ito S, Inoue K, Yonezawa A, Katsura T, Kumagai Y, Yuasa H, Moriyama Y, Inui K, Kusuhara H, Sugiyama Y
-
Journal Title
Pharm. Res
Volume: 31
Pages: 136-147
Peer Reviewed
-
-
-
[Journal Article] Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer2013
Author(s)
Fukudo M, Ikemi Y, Togashi Y, Masago K, Kim YH, Mio T, Terada T, Teramukai S, Mishima M, Inui K, Katsura T
-
Journal Title
Clin. Pharmacokinet
Volume: 52
Pages: 593-609
Peer Reviewed
-
-
-
-
[Journal Article] Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer2012
Author(s)
Togashi Y, Masago K, Masuda S, Mizuno T, Fukudo M, Ikemi Y, Sakamori Y, Nagai H, Kim YH, Katsura T, Mishima M
-
Journal Title
Cancer Chemother. Pharmacol
Volume: 70
Pages: 399-405
Peer Reviewed
-
-
-
[Journal Article] Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation2011
Author(s)
Togashi Y, Masago K, Fukudo M, Tsuchido Y, Okuda C, Kim YH, Ikemi Y, Sakamori Y, Mio T, Katsura T, Mishima M
-
Journal Title
Cancer Chemother. Pharmacol
Volume: 68
Pages: 1089-1092
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-